Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Ethicon Advances Obesity Solutions Through Research, Surgical Training And Innovation Showcased During ObesityWeek

Ethicon
Posted on: 01 Nov 16

PR Newswire

NEW ORLEANS, Nov. 1, 2016

NEW ORLEANS, Nov. 1, 2016 /PRNewswire/ -- Ethicon* joins world-renowned experts in bariatric surgery to share the latest breakthroughs in science and innovation that are advancing surgery in the fight against obesity and metabolic diseases during ObesityWeek 2016, the combined annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS).  Ethicon will highlight the growing body of research and evidence on the benefits of bariatric surgery, a new sleeve gastrectomy training module on the Touch Surgery app, and its comprehensive portfolio of bariatric surgery products aimed to improve patient outcomes.

Experience the interactive Multimedia News Release here: https://www.multivu.com/players/English/7965651-ethicon-bariatric-surgery-access-obesity-week-2016

"Ethicon's mission is to lead the way in resolving the burden of obesity for both patients and healthcare systems by expanding access to care and demonstrating the critical value of treatment through research and evidence, while also enabling new technologies," said Dr. Elliott Fegelman, Therapeutic Area Expert, Metabolics, Johnson & Johnson Innovation.

Growing evidence on the multiple benefits of bariatric surgery
Ethicon is committed to driving a deeper understanding of bariatric surgery and its impact on patient outcomes, including which patients see the greatest impact from specific surgical procedures. By investing in and leveraging a growing body of clinical research and evidence, Ethicon is advancing a global conversation on bariatric surgery as a potentially health-improving procedure for patients suffering from obesity and obesity-related health conditions. Recent evidence includes:

  • Accepted as a late-breaking podium presentation at ObesityWeek, Partial Jejunal Diversion (PJD): A Novel Approach to Glycemic Control in Type 2 Diabetes Mellitus (T2DM) highlights research from Ethicon's Metabolic Applied Research Strategy (MARS) program related to PJD and its impact on the glycemic index.
  • The STAMPEDE (Surgical Treatment And Medications Potentially Eradicate Diabetes Efficiently) trial was designed to compare intensive medical therapy (IMT) with and without bariatric surgery as a means to improve glycemic control in obese patients with uncontrolled type 2 diabetes (T2DM).

New education programs and training to raise the standard of care
At ObesityWeek, Ethicon is sponsoring a highly interactive program, The Case for Revisional Bariatric Surgery, where Dr. Kelvin Higa and Dr. Eric DeMaria will lead a discussion on the efficacy and challenges of revisional bariatric surgery. In addition, Ethicon will host several presentations with key thought leaders in booth #301, including:

  • "Current and New Approaches to Duodenal Switch" (Dr. Mitchell Roslin/Dr. Peter Ng)
  • "Building the Successful and Thriving Bariatric Program" (Dr. Stan Hoehn/Dr. Shawn Garber)
  • "Bariatric Surgery for Orthopaedic Patients" (Dr. John Morton/Dr. John Bottros)

As a result of Ethicon's strategic collaboration with Touch Surgery, Ethicon will launch a new sleeve gastrectomy procedure simulation. The new simulation is part of a broader commitment to provide digital content on the Touch Surgery platform that allows surgeons and surgeon trainees to educate themselves anytime, anywhere.

Advances in product innovation for optimal surgery outcomes
Ethicon will feature its comprehensive portfolio of bariatric surgery products designed to minimize the impact surgical procedures have on living tissue, improve patient outcomes and advance healing.  Among the product innovations featured are:

  • ECHELON FLEX™ GST System †: Uniquely designed with better grip to provide the least tissue slippage during firing of any Endocutter for unsurpassed stapling performance in bariatric surgery[i]. ECHELON FLEX GST is the most chosen Endocutter in bariatric surgery[ii].
  • HARMONIC ACE® +7 Shears with Advanced Hemostasis: Provides the multi-functionality needed to improve procedural efficiency and minimize instrument exchanges when mobilizing the stomach. HARMONIC® Technology is used in more bariatric procedures than any other advanced energy device[iii].
  • STRATAFIX™ Knotless Tissue Control Devices: Provides more consistency, more security and more efficiency compared to traditional sutures. Trust built on 40 years of performance of the #1 suture worldwide[iv] [v] [vi].

To learn more about Ethicon's commitment to shaping the future of surgery in the fight against obesity and metabolic diseases, visit http://www.ethicon.com/healthcare-professionals/specialties/bariatric-surgery.

About Ethicon
From creating the first sutures, to revolutionizing surgery with minimally invasive procedures, Ethicon, part of the Johnson & Johnson Family of Companies, has made significant contributions to surgery for more than 60 years. Our continuing dedication to Shape the Future of Surgery is built on our commitment to help address the world's most pressing health care issues, and improve and save more lives. Through Ethicon's surgical technologies and solutions including sutures, staplers, energy devices, trocars and hemostats and our commitment to treat serious medical conditions like obesity and cancer worldwide, we deliver innovation to make a life-changing impact. Learn more at www.ethicon.com, and follow us on Twitter @Ethicon.

MEDIA CONTACT:
Krystina Monaco
513-337-8256
kmonaco@its.jnj.com 

* Ethicon represents the products and services of Ethicon, Inc., Ethicon Endo-Surgery, LLC and certain of their affiliates.

Participating surgeons are paid representatives of Ethicon.

062214-161025  

[i] Benchtop testing in porcine stomach tissue. Mean tissue movement from after clamping on tissue to after firing ECHELON FLEX Powered Plus Stapler (PSEE60A) and ECHELON Reload with GST vs ENDO GIA™ULTRA Handle (EGIAUSTND) and Endo GIA Reload with Tri-Staple™ Technology at 1.5, 2.5, 3.3 and 4.0mm tissue thicknesses (1.5mm: GST60B 1.067mm vs EGIA60AMT 2.452mm p<0.001; 2.5mm: GST60G 1.148mm vs EGIA60AMT 3.261mm p<0.001; 3.3mm: GST60T 0.642mm vs EGIA60AMT 4.806mm p<0.001; 4.0mm: GST60T 0.654mm vs EGIA60AXT 5.116mm p<0.001)
[ii] DRG data from June 2016 YTD, comparing units sold as reported by DRG for long stapler codes (PLEE60A, PLE60A, LONG60A, LONG60 compared to EGIAUXL, EGIAUNIVXL).
[iii] Per US data compiled from Truven Health Analytics and Premier Hospital Inpatient Chargemaster (2014)
[iv] Based on revenue share, 2013
[v] Refers to Coated VICRYL® (polyglactin 910) Suture
[vi] Data on file, Ethicon, Inc.: Suture market data 2013.

†System components include ECHELON FLEX™ Powered Plus Stapler and ENDOPATH ECHELON™ Reloads with Gripping Surface Technology

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ethicon-advances-obesity-solutions-through-research-surgical-training-and-innovation-showcased-during-obesityweek-300354769.html

SOURCE Ethicon

PR Newswire
www.prnewswire.com

Last updated on: 01/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.